Skip to content

Direxion Daily Healthcare Bull 3X ETF

CURENYSE ArcaAThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.

$131.19−5.59 (−4.09%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 79 prints from 136.78 to 131.19. Range 131.05 to 136.96. Use the arrow keys to read each point.132.00133.00134.00135.00136.0010 AM12 PM2 PM4 PM
Expense ratio
0.94%
Fund size
$168M
1Y total return
+57.0%
Yield · Last 12 months
0.92%
Holdings
67
Avg volume · 30D
0.1M sh
NAV per share
$134.07
52W range
low $82.41high $150.00
Launched
Filings
SEC EDGAR

The ETF.net CURE Grade

Based on 4 of 6 pillars

A

Score 73 out of 100

Rank
3 of 31
Six-pillar profile for CURE. Scores out of 100: Cost 88, Risk 69, Mission not scored, Tradability 55, Holdings not scored, Durability 52. Strongest: Cost (88). Weakest: Durability (52). Based on 4 of 6 pillars.

Score 73 of 100 falls in the A band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A88 out of 100
    Rank 4 of 31
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B69 out of 100
    Rank 3 of 30
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B55 out of 100
    Rank 14 of 31
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    Not scored
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C52 out of 100
    Rank 14 of 31

Our read on CURE

ETF.net Research

AHealthcare is the market's defensive sector. CURE straps three-times daily leverage to it, aiming for 300% of the Health Care Select Sector Index's daily move across drugmakers, insurers and device names. A trading tool with a one-day clock, running since 2011.

Stated mandate

The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the Health Care Select Sector Index.

Why people hold it

  1. 01Fee is 0.94%, below what the typical leveraged bull fund charges. On a geared product you rent by the day, that gap is real money.
  2. 02One job, plainly stated: 300% of the daily performance of the Health Care Select Sector Index, roughly 70 large-cap US healthcare names. No stock picking, no style drift.direxion.com
  3. 03Trading since 2011, a long tenure for a geared sector fund, and one of the stronger builds among leveraged bull ETFs.

Worth knowing

  1. 01The leverage resets every day. Hold past the closing bell and compounding takes over, so multi-day results can land far from 3x the index over that stretch.
  2. 02Gearing is symmetrical. A bad day for healthcare, drug-pricing headlines or an FDA surprise, comes through roughly tripled.
  3. 03One sector, about 70 stocks, then leverage on top. Concentration and gearing stack, so daily swings dwarf a broad-market fund's.

CURE Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
67
Top-10 weight
86%
Largest holding
Ixv Swap Asset Leg (Ixvbcl)30.6%

Sectors

  • Health Care99.3%
  • Technology0.7%

Geography

  • United States97.83%
  • Ireland2.17%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001—Ixv Swap Asset Leg (Ixvbcl)30.57%97,068$168M1
002—Ixv Swap Asset Leg (Ixvjpl)14.50%46,028$80M1
003—Ixv Swap Asset Leg (Ixvubl)14.17%45,000$78M1
004—Ixv Swap Asset Leg (Ixvctl)11.20%35,551$61M1
005—Dreyfus Govt Cash Man Ins4.83%26,518,882$27M108
006LLYEli Lilly & Co3.23%15,037$18M583
007—Goldman Sachs Fin Gov 465 Institut2.61%14,304,800$14M76
008JNJJohnson & Johnson2.16%45,289$12M528
009ABBVAbbVie Inc1.67%33,209$9M522
010MRKMerck & Co. Inc.1.23%46,365$7M515
011UNHUnitedHealth Group Inc1.17%16,868$6M481
012—Goldman Finl Sq Trsry Inst 5060.90%4,913,165$5M98
013TMOThermo Fisher Scientific Inc0.83%6,949$5M375
014AMGNAmgen Inc0.77%10,160$4M491
015GILDGilead Sciences Inc0.64%23,302$4M492

Showing 1–15 of 67 holdings

CURE Performance

Launched Jun 15, 2011

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

CURE$15,695
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. CURE $15,695. SPY $12,044. Use the arrow keys to read each point.$8,944$13,232$17,519Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for CURE. Periods over one year show the average yearly return.
PeriodCURE
Year to date+23.8%
1 month+12.5%
3 months+18.0%
1 year+57.0%
3 yearsper year+16.7%
5 yearsper year+7.2%
10 yearsper year+17.6%

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for CURE
YearReturn barCURE
2026 YTD+23.8%
2025+22.5%
2024−8.5%
2023−9.4%
2022−20.5%
2021+88.3%
2020+4.9%

CURE in the news

Filtered to CURE · 3x Leveraged Long · Direxion

CURE Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
0.92%Last 12 months
Payout per share
$1.26Last 12 months
Last payment
$0.32 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 32 payments from 2017 to 2026 YTD. Dec 13, 2017 $0.02; Dec 19, 2017 $0.07; Jun 19, 2018 $0.11; Sep 25, 2018 $0.09; Dec 27, 2018 $0.14; Mar 19, 2019 $0.09; Sep 24, 2019 $0.20; Dec 23, 2019 $0.00006; Mar 24, 2020 $0.10; Jun 23, 2020 $0.02; Sep 22, 2020 $0.01; Dec 22, 2020 $0.0061; Dec 21, 2021 $0.03; Mar 22, 2022 $0.04; Jun 22, 2022 $0.08; Sep 20, 2022 $0.18; Dec 20, 2022 $0.14; Mar 21, 2023 $0.49; Jun 21, 2023 $0.54; Sep 19, 2023 $0.45; Dec 21, 2023 $0.57; Mar 19, 2024 $0.36; Jun 25, 2024 $0.27; Sep 24, 2024 $0.33; Dec 23, 2024 $0.12; Mar 25, 2025 $0.35; Jun 24, 2025 $0.31; Sep 23, 2025 $0.31; Dec 23, 2025 $0.29; Mar 24, 2026 $0.28; Jun 23, 2026 $0.37; Sep 22, 2026 $0.32. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 22, 2026Sep 29, 2026$0.32
Jun 23, 2026Jun 30, 2026$0.37
Mar 24, 2026Mar 31, 2026$0.28
Dec 23, 2025Dec 31, 2025$0.29
Sep 23, 2025Sep 30, 2025$0.31
Jun 24, 2025Jul 1, 2025$0.31
Mar 25, 2025Apr 1, 2025$0.35
Dec 23, 2024Dec 31, 2024$0.12
Sep 24, 2024Oct 1, 2024$0.33
Jun 25, 2024Jul 2, 2024$0.27
Mar 19, 2024Mar 26, 2024$0.36
Dec 21, 2023Dec 29, 2023$0.57

CURE Risk

This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.

How much the fund’s monthly returns vary, scaled to a year.
42.5%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.43
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−52.3%
Trough Aug 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.27
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

CURE Cost

Expense ratio0.94%
  • The middle half of 3x Leveraged Long funds
  • Median 0.98%

3 of the 30 3x Leveraged Long funds charge less.

CURE costs $94.00 a year on $10,000. The median 3x Leveraged Long fund costs $98.50.

Other funds in 3x Leveraged Long